» Articles » PMID: 37861683

Dynamic Choice HIV Prevention Intervention at Outpatient Departments in Rural Kenya and Uganda

Abstract

Objective: HIV prevention service delivery models that offer product choices, and the option to change preferences over time, may increase prevention coverage. Outpatient departments in sub-Saharan Africa diagnose a high proportion of new HIV infections, but are an understudied entry point to biomedical prevention.

Design: Individually randomized trial of dynamic choice HIV prevention (DCP) intervention vs. standard-of-care (SOC) among individuals with current/anticipated HIV exposure risk at outpatient departments in rural Kenya and Uganda (SEARCH; NCT04810650).

Methods: Our DCP intervention included 1) product choice (oral preexposure prophylaxis [PrEP] or postexposure prophylaxis [PEP]) with an option to switch over time, 2) HIV provider- or self-testing, 3) service location choice (community vs. clinic-based), and 4) provider training on patient-centered care. Primary outcome was proportion of follow-up covered by PrEP/PEP over 48 weeks assessed via self-report.

Results: We enrolled 403 participants (61% women; median 27 years, IQR 22-37). In the DCP arm, 86% ever chose PrEP, 15% ever chose PEP over 48 weeks; selection of HIV self-testing increased from 26 to 51% and of out-of-facility visits from 8 to 52%. Among 376 of 403 (93%) with outcomes ascertained, time covered by PrEP/PEP was higher in DCP (47.5%) vs. SOC (18.3%); difference = 29.2% (95% confidence interval: 22.7-35.7; P  < 0.001). Effects were similar among women and men (28.2 and 31.0% higher coverage in DCP, respectively) and larger during periods of self-reported HIV risk (DCP 64.9% vs. SOC 26.3%; difference = 38.6%; 95% confidence interval: 31.0-46.2; P  < 0.001).

Conclusion: A dynamic choice HIV prevention intervention resulted in two-fold greater time covered by biomedical prevention products compared to SOC in general outpatient departments in eastern Africa.

Citing Articles

Preventing HIV in women in Africa.

Cowan F, Shahmanesh M, Revill P, Busza J, Sibanda E, Chabata S Nat Med. 2025; .

PMID: 39948405 DOI: 10.1038/s41591-025-03535-8.


A pilot cluster randomized controlled trial assessing uptake of PrEP and contraception in hair salons in South Africa.

Bassett I, Yan J, Govere S, Shezi S, Ngcobo L, Sagar S BMC Public Health. 2025; 25(1):524.

PMID: 39922997 PMC: 11806743. DOI: 10.1186/s12889-025-21718-3.


Dynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and Kenya: a randomised trial extension.

Kamya M, Balzer L, Ayieko J, Kabami J, Kakande E, Chamie G Lancet HIV. 2024; 11(11):e736-e745.

PMID: 39395424 PMC: 11753513. DOI: 10.1016/S2352-3018(24)00235-2.


PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice.

McGuire C, Atieno M, Hoke T, Jeckonia P, Korimba K, Lorenzetti L Curr HIV/AIDS Rep. 2024; 21(5):282-292.

PMID: 39046639 PMC: 11377463. DOI: 10.1007/s11904-024-00704-1.

References
1.
Mayanja Y, Kamacooko O, Lunkuse J, Muturi-Kioi V, Buzibye A, Omali D . Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study. J Int AIDS Soc. 2022; 25(5):e25909. PMC: 9092160. DOI: 10.1002/jia2.25909. View

2.
Marrazzo J, Ramjee G, Richardson B, Gomez K, Mgodi N, Nair G . Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015; 372(6):509-18. PMC: 4341965. DOI: 10.1056/NEJMoa1402269. View

3.
Ayieko J, Petersen M, Kamya M, Havlir D . PEP for HIV prevention: are we missing opportunities to reduce new infections?. J Int AIDS Soc. 2022; 25(5):e25942. PMC: 9142817. DOI: 10.1002/jia2.25942. View

4.
Okochi H, Louie A, Phung N, Zhang K, Tallerico R, Kuncze K . Tenofovir and emtricitabine concentrations in hair are comparable between individuals on tenofovir disoproxil fumarate versus tenofovir alafenamide-based ART. Drug Test Anal. 2021; 13(7):1354-1370. PMC: 9131373. DOI: 10.1002/dta.3033. View

5.
Dietrich J, Atujuna M, Tshabalala G, Hornschuh S, Mulaudzi M, Koh M . A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa. BMC Health Serv Res. 2021; 21(1):17. PMC: 7788832. DOI: 10.1186/s12913-020-05942-8. View